<DOC>
	<DOCNO>NCT01818973</DOCNO>
	<brief_summary>We presume addition monoclonal antibody Bevacizumab radiation therapy combination chemotherapy could result improve pathologic tumor regression grade ( TRG ) locally advanced nonmetastatic rectal cancer .</brief_summary>
	<brief_title>Preoporative Bevacizumab , Radiation Therapy , XELOX Chemotherapy Locally Advanced Nonmetastatic Rectal Cancer</brief_title>
	<detailed_description>Monoclonal antibody , bevacizumab , block tumor growth different way . Giving bevacizumab together radiation therapy combination chemotherapy surgery may achieve promise improvement pCR rate , design Phase II study patient T3/4 N1/2 loco-regionally advance rectum cancer , examine efficacy safety addition bevacizumab regimen capecitabine oxaliplatin combination pre-operative radiation .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Histologically confirm adenocarcinoma colon rectum . T3 T4 adenocarcinoma node positive colorectal tumour . Appropriate stag investigation primary tumour , either endorectal ultrasound pelvic MRI . Male female age 18 70 . Have performance status ECOG 0 1 . Have life expectancy great 6 month . Adequate organ function coagulation parameter measure : WBC &gt; 4000/mm3 , PLT &gt; 100000/mm3 , Hb &gt; 10g/dL , ALT &lt; 1.5X ULN , AST &lt; 1.5X ULN , bilirubin &lt; 1.5mg/dL Serum creatinine &lt; 1.8mg/dL . Patient consent . Known clinical radiological evidence distant metastasis . Evidence intestinal obstruction ( except enterostomy ) . Patients past history colorectal surgery ( except enterostomy ) , chemtherapy , radiation , biotherapy target therapy . Pregnant woman OR woman childbearing potential positive pregnancy test baseline lactating . Sexually active male female ( childbearing potential ) unwilling practice contraception study . Patients past current history ( within last 5 year ) malignancy , except indication study curatively treat basal squamous skin cancer insitu cancer cervix . Patients mental disorder unable complete inform consent . Uncontrolled hypertension . Clinically significant ( i.e . active ) cardiovascular disease example : cerebrovascular accident ( &lt; =6 month ) , myocardial infarction ( &lt; = 6 month ) , unstable angina , New York Heart Association ( NYHA ) grade II great congestive heart failure , serious cardiac arrhythmia require medication . Moderate serious proteinuria . Known hypersensitivity experimental drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Rectal Cancer</keyword>
	<keyword>Bevacizumab</keyword>
	<keyword>capecitabine</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>preoporative IMRT</keyword>
</DOC>